Efficacy of Nityavirechana in Management Of Essential Hypertension - An Open Clinical Trial
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 15
- 试验地点
- 1
- 主要终点
- Nitya Virechana is efficient in management of Hypertension. And able to reduce the systolic BP below 130mmHg
研究概览
简要总结
Hypertension is considered as one of the most common disorder globally mainly due to changing lifestyle, obesity ,smoking,alcohol,dietary changes, etc.
The prevalence rate of Hypertension in India is 52.3% also previous studies indicate that 40.3% for the age group of 30-74 years with Stage-1 hypertension have a 10 year risk of developing cardiovascular disease.1
Long term hypertension is a major risk for coronary heart disease ,stroke,heart failure ,atrial fibrillations, peripheral arterial disease ,vision loss, chronic kidney disease , dementia,organ malfunction.2
According to contemporary medicine the existing treatment modalities for hypertension viz ACE inhibitors, β -blockers have following side effects- dizziness,headache, hypotension, hypoglycemia, bradycardia, debility, impotence,GERD, drowsiness, constipation.3
In Ayurveda ,hypertension can be considered one among shonita dushti, virechana is considered pradhana chikitsa for shonita vikara which can result in sharira shodhana and hridya/ sroto-vishudhi .
Hence an attempt is made to evaluate the role of virechana karma in hypertension
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Open Label
入排标准
- 年龄范围
- 30.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients presenting with signs and symptoms of hypertension Patients with known case of hypertension Patients suffering from Stage1 hypertension Patients fit for virechana.
排除标准
- •Patients suffering from secondary hypertension Patients with Stage 2 and Stage 3 hypertension.
结局指标
主要结局
Nitya Virechana is efficient in management of Hypertension. And able to reduce the systolic BP below 130mmHg
时间窗: 0th day1st 2nd & 3rd day 4th day19th day
次要结局
- NOT APPLICABLE(NOT APPLICABLE)